Thomas E. Hickey

1.4k total citations
17 papers, 1.0k citations indexed

About

Thomas E. Hickey is a scholar working on Food Science, Infectious Diseases and Endocrinology. According to data from OpenAlex, Thomas E. Hickey has authored 17 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Food Science, 7 papers in Infectious Diseases and 4 papers in Endocrinology. Recurrent topics in Thomas E. Hickey's work include Salmonella and Campylobacter epidemiology (8 papers), Escherichia coli research studies (4 papers) and Viral gastroenteritis research and epidemiology (3 papers). Thomas E. Hickey is often cited by papers focused on Salmonella and Campylobacter epidemiology (8 papers), Escherichia coli research studies (4 papers) and Viral gastroenteritis research and epidemiology (3 papers). Thomas E. Hickey collaborates with scholars based in United States, Ireland and Germany. Thomas E. Hickey's co-authors include Patricia Guerry, Cheryl P. Ewing, Martina M. Prendergast, Anthony P. Moran, A. Louis Bourgeois, Lan Hu, Daniel A. Scott, Annette L. McVeigh, Christine M. Szymanski and James B. Delehanty and has published in prestigious journals such as Infection and Immunity, Frontiers in Immunology and Bioorganic & Medicinal Chemistry.

In The Last Decade

Thomas E. Hickey

17 papers receiving 989 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas E. Hickey United States 12 694 484 229 215 151 17 1.0k
Lindsay M. Davis United States 7 645 0.9× 406 0.8× 167 0.7× 228 1.1× 180 1.2× 7 905
Ruijin Yao United States 9 664 1.0× 337 0.7× 359 1.6× 306 1.4× 344 2.3× 12 1.1k
Kei‐ichi Uchiya Japan 17 281 0.4× 396 0.8× 145 0.6× 327 1.5× 301 2.0× 50 1.1k
Donald H. Burr United States 13 396 0.6× 279 0.6× 207 0.9× 228 1.1× 244 1.6× 16 818
Denis Brochu Canada 17 424 0.6× 326 0.7× 152 0.7× 107 0.5× 467 3.1× 34 1.2k
Dominic C. Mills United Kingdom 16 412 0.6× 211 0.4× 253 1.1× 234 1.1× 646 4.3× 21 1.3k
Emilisa Frirdich Canada 19 390 0.6× 207 0.4× 269 1.2× 373 1.7× 436 2.9× 25 1.2k
Annie Aubry Canada 19 231 0.3× 332 0.7× 289 1.3× 157 0.7× 790 5.2× 30 1.4k
Ján Burian Canada 19 149 0.2× 312 0.6× 162 0.7× 132 0.6× 367 2.4× 38 941
Juan E. Ugalde Argentina 18 240 0.3× 127 0.3× 204 0.9× 354 1.6× 333 2.2× 42 1.2k

Countries citing papers authored by Thomas E. Hickey

Since Specialization
Citations

This map shows the geographic impact of Thomas E. Hickey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Hickey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Hickey more than expected).

Fields of papers citing papers by Thomas E. Hickey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Hickey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Hickey. The network helps show where Thomas E. Hickey may publish in the future.

Co-authorship network of co-authors of Thomas E. Hickey

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Hickey. A scholar is included among the top collaborators of Thomas E. Hickey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Hickey. Thomas E. Hickey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kemp, Troy J., et al.. (2025). Circulating SARS-CoV-2 spike IgG antibody responses in cancer patients following multiple COVID-19 vaccination boosters. Frontiers in Immunology. 16. 1629473–1629473. 1 indexed citations
2.
Hickey, Thomas E., Troy J. Kemp, Jordan B. Metz, et al.. (2024). Longitudinal Assessment of BNT162b2- and mRNA-1273-Induced Anti-SARS-CoV-2 Spike IgG Levels and Avidity Following Three Doses of Vaccination. Vaccines. 12(5). 516–516. 6 indexed citations
3.
Hickey, Thomas E., Troy J. Kemp, Jordan B. Metz, et al.. (2023). SARS-CoV-2 IgG Spike antibody levels and avidity in natural infection or following vaccination with mRNA-1273 or BNT162b2 vaccines. Human Vaccines & Immunotherapeutics. 19(2). 2215677–2215677. 8 indexed citations
4.
Mytle, Nutan, Jon R. Inglefield, Andrea M. Harris, et al.. (2021). Influenza Antigens NP and M2 Confer Cross Protection to BALB/c Mice against Lethal Challenge with H1N1, Pandemic H1N1 or H5N1 Influenza A Viruses. Viruses. 13(9). 1708–1708. 7 indexed citations
5.
Knight, D. Andrew, et al.. (2010). Differential effects of Co(III), Ni(II), and Ru(III) amine complexes on Sindbis virus. Journal of Inorganic Biochemistry. 104(5). 592–598. 12 indexed citations
6.
Delehanty, James B., et al.. (2007). Antiviral properties of cobalt(III)-complexes. Bioorganic & Medicinal Chemistry. 16(2). 830–837. 39 indexed citations
7.
Hickey, Thomas E., et al.. (2007). Dimethylamino-functionalised and N-heteroaryl-substituted titanocene anticancer drugs: synthesis and cytotoxicity studies. Investigational New Drugs. 25(5). 425–433. 11 indexed citations
8.
Hogan, Megan, et al.. (2007). Synthesis and Cytotoxicity Studies of Titanocene C Analogues. Metal-Based Drugs. 2008. 1–7. 6 indexed citations
9.
Poly, Frédéric, Cheryl P. Ewing, Scarlett Goon, et al.. (2007). Heterogeneity of a Campylobacter jejuni Protein That Is Secreted through the Flagellar Filament. Infection and Immunity. 75(8). 3859–3867. 74 indexed citations
10.
Delehanty, James B., Brandy J. Johnson, Thomas E. Hickey, Thomas Pons, & Frances S. Ligler. (2007). Binding and Neutralization of Lipopolysaccharides by Plant Proanthocyanidins. Journal of Natural Products. 70(11). 1718–1724. 60 indexed citations
11.
Hickey, Thomas E., et al.. (2005). Intracellular Survival of Campylobacter jejuni in Human Monocytic Cells and Induction of Apoptotic Death by Cytholethal Distending Toxin. Infection and Immunity. 73(8). 5194–5197. 70 indexed citations
12.
Hu, Lan & Thomas E. Hickey. (2005). Campylobacter jejuni Induces Secretion of Proinflammatory Chemokines from Human Intestinal Epithelial Cells. Infection and Immunity. 73(7). 4437–4440. 41 indexed citations
13.
Bacon, David, Richard A. Alm, Lan Hu, et al.. (2002). DNA Sequence and Mutational Analyses of the pVir Plasmid of Campylobacter jejuni 81-176. Infection and Immunity. 70(11). 6242–6250. 109 indexed citations
14.
Guerry, Patricia, Christine M. Szymanski, Martina M. Prendergast, et al.. (2002). Phase Variation ofCampylobacter jejuni81-176 Lipooligosaccharide Affects Ganglioside Mimicry and Invasiveness In Vitro. Infection and Immunity. 70(2). 787–793. 168 indexed citations
15.
Guerry, Patricia, Cheryl P. Ewing, Thomas E. Hickey, Martina M. Prendergast, & Anthony P. Moran. (2000). Sialylation of Lipooligosaccharide Cores Affects Immunogenicity and Serum Resistance of Campylobacter jejuni. Infection and Immunity. 68(12). 6656–6662. 105 indexed citations
16.
Hickey, Thomas E., et al.. (2000). Campylobacter jejuniCytolethal Distending Toxin Mediates Release of Interleukin-8 from Intestinal Epithelial Cells. Infection and Immunity. 68(12). 6535–6541. 200 indexed citations
17.
Hickey, Thomas E., et al.. (1999). Campylobacter jejuni -Stimulated Secretion of Interleukin-8 by INT407 Cells. Infection and Immunity. 67(1). 88–93. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026